ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology.
about
Available and emerging treatments for Parkinson's disease: a reviewNanotechnology, nanotoxicology, and neuroscienceGold nanorod--siRNA induces efficient in vivo gene silencing in the rat hippocampus.Chronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal tumor necrosis factorIncreasing TNF levels solely in the rat hippocampus produces persistent pain-like symptomsNonviral gene transfection nanoparticles: function and applications in the brain.Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.CD151 mediates netrin-1-induced angiogenesis through the Src-FAK-Paxillin pathway.Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.Novel luminescent silica nanoparticles (LSN): p53 gene delivery system in breast cancer in vitro and in vivo.Organosilica hybrid nanomaterials with a high organic content: syntheses and applications of silsesquioxanes.Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process.Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticlesTheranostic applications of nanoparticles in neurodegenerative disorders
P2860
Q24633444-902B0A99-7BD2-46BD-8C77-B992AE2691EBQ24650444-DDFED26F-9B17-400B-AF8D-A22C9C2F0352Q35093276-78977BBF-EA87-4303-9816-F1798682B380Q35597102-39982E67-2D6B-4483-A787-2298C05FCF9AQ36160364-2D4F80FE-8189-4BB2-9A70-B33338BE90C9Q37099839-ACD3349A-41FA-4DE2-961F-8FC85F8CC92BQ37302933-D33CEF3F-E3E8-4C10-8599-410CEC4D8505Q38750316-AC7AD95D-2D7C-4AF2-9BA7-FA8FDF5B2F29Q38761724-90C36098-CC3B-485C-A5D4-795B52C91BDEQ38777583-BDCDB491-4D4D-4DFF-850D-9242ED8F4D9DQ39023379-C10BD1F9-2AF4-47B5-A72A-494B99166C4DQ39112084-7D4262D5-4259-4C41-82BD-3EF644B8351CQ39219446-584BCCA9-3F54-40D6-9AAE-FEC3149157D6Q57071940-9C1B3137-9D2B-4445-BA99-0FC30287D3FD
P2860
ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
ORMOSIL nanoparticles as a non ...... amine induced brain pathology.
@ast
ORMOSIL nanoparticles as a non ...... amine induced brain pathology.
@en
type
label
ORMOSIL nanoparticles as a non ...... amine induced brain pathology.
@ast
ORMOSIL nanoparticles as a non ...... amine induced brain pathology.
@en
prefLabel
ORMOSIL nanoparticles as a non ...... amine induced brain pathology.
@ast
ORMOSIL nanoparticles as a non ...... amine induced brain pathology.
@en
P2093
P1476
ORMOSIL nanoparticles as a non ...... amine induced brain pathology.
@en
P2093
Bharali DJ
Stachowiak EK
Stachowiak MK
P304
P356
10.1016/J.JNEUMETH.2007.06.011
P577
2007-06-19T00:00:00Z